scispace - formally typeset
S

Shenping Liu

Researcher at Pfizer

Publications -  43
Citations -  1866

Shenping Liu is an academic researcher from Pfizer. The author has contributed to research in topics: Glucokinase & Binding site. The author has an hindex of 22, co-authored 41 publications receiving 1598 citations.

Papers
More filters
Journal ArticleDOI

Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.

TL;DR: The structure of the catalytic complex of GK has been determined, and multiple conformations have been directly observed in solution, and a modified mnemonic model is proposed to explain cooperativity in GK.
Journal ArticleDOI

Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.

TL;DR: The structure-based design of a highly selective inhibitor of the CREB binding protein (CBP) bromodomain is described and its use in cell-based transcriptional profiling experiments is described, suggesting a potential therapeutic opportunity for CBP inhibitors in the treatment of neurological disorders.
Journal ArticleDOI

Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide

TL;DR: A high affinity IL-17A peptide antagonist (HAP) of 15 residues was identified through phage-display screening followed by saturation mutagenesis optimization and amino acid substitutions and suggests opportunities for developing peptide antagonists against this challenging target.